Call for Papers
(Specific to Molecular and Cellular Probes)
Liquid Biopsy Technologies in Precision Oncology
Authors Guide:
Molecular and Cellular Probes has evolved into a one-of-a-kind venue for genomic, proteomic, and immunological research on the localization, diagnosis, and monitoring of hereditary and infectious illnesses. Crossing traditional diagnostic and clinical medical borders, the publication serves as a good common meeting place for workers from several areas.
Submission:
The Editor-in-Chief will evaluate the proposal based on its relevance, freshness, and timeliness. If your application is accepted, you may be required to supply further information so that the electronic submission site can be set up.
Therapeutic disease:
Precision medicine represents a paradigm change in clinical oncology since it allows for tailored therapy optimization, resulting in improved efficacy and perhaps fewer detrimental side effects than traditional therapeutic techniques. Unfortunately, tumour biopsy-based molecular assays are not always viable due to inaccessible or inadequate material. Liquid biopsy is an essential precision oncology tool because it allows for early diagnosis, real-time prognosis, and longitudinal monitoring for resistance discovery in cancer patients while avoiding the disadvantages of traditional biopsy procedures. Circulating tumor cells and DNA (CTCs, ctDNA), non-coding RNA (ncRNA) molecules, and extracellular vesicles (EVs), in particular, are garnering interest as prospective indicators for several forms of cancer.
Pubrica Offers:
Pubrica assists in the creation of clinical case reports for uncommon illnesses. Pubrica provides comprehensive publishing assistance for many periodicals, journals, and books. We will be with you throughout the publication process, from interpreting your vision to writing an insightful report. We help medical professionals, students, hospitals, and pharmaceutical and device makers find a reliable writing partner. We have expertise in life science, medicine, and technology. We can publish in high-impact journals such as Nature Reviews Cancer, Journal of Clinical Oncology, Cancer Cell, Journal of the National Cancer Institute, Cancer immunology research, Clinical Cancer Research, Drug Resistance Updates, Cancer Research, and others because of our consistent, high-quality writing.
